1,387
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

The microRNA-381(miR-381)/Spindlin1(SPIN1) axis contributes to cell proliferation and invasion of colorectal cancer cells by regulating the Wnt/β-catenin pathway

, , , , , , , , & ORCID Icon show all
Pages 12036-12048 | Received 21 Sep 2021, Accepted 03 Nov 2021, Published online: 27 Dec 2021

References

  • Keum N, Giovannucci EJ. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev . 2019;16(12):713–732.
  • Dekker E, Tanis P, Vleugels J, et al. Colorectal cancer. Lancet (London, England). 2019;394:1467–1480.
  • Yue W, Sun L, Li C, et al. [Screening and identification of ovarian carcinomas related genes]. Ai Zheng = Aizheng = Chin J Cancer. 2004;23:141–145.
  • Su X, Zhu G, Ding X, et al. Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin/Ssty repeats of Spindlin1. Genes Dev. 2014;28:622–636.
  • Chen X, Wang Y, Gao PJ. SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer. J Exp Clin Cancer Res CR. 2018;37:100.
  • Zhao M, Bu Y, Feng J, et al. SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer. Cancer Lett. 2020;470:54–63.
  • Lv B, Ma R, Chen X, et al. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer. Mol Oncol. 2020;14:2629–2645.
  • Jin Y, Su Z, Sheng H, et al. Circ_0086720 knockdown strengthens the radiosensitivity of non-small cell lung cancer via mediating the miR-375/SPIN1 axis. Neoplasma. 2021;68:96–107.
  • Fang Z, Cao B, Liao J, et al. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer. 2018;7:e31275.
  • Li D, Guo J, Jia R. Histone code reader SPIN1 is a promising target of cancer therapy. Biochimie. 2021;191:78–86.
  • Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science (New York, N.Y.). 2001;294(5543):853–858.
  • Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23(1):175–205.
  • Akbari A, Sedaghat M, Heshmati J, et al. Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers. Biomed Pharmacother. 2021;141:111849.
  • Cai L, Ye L, Hu X, et al. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4. Bioengineered. 2021;12(1):440–449.
  • Jinghua H, Qinghua Z, Chenchen C, et al. MicroRNA miR-92a-3p regulates breast cancer cell proliferation and metastasis via regulating B-cell translocation gene 2 (BTG2). Bioengineered. 2021;12:2033–2044.
  • Akbari A, Majd HM, Rahnama R, et al. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: focused on gastrointestinal cancers. Biomed Pharmacother. 2020;131:110729.
  • He X, Wei Y, Wang Y, et al. MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1. Onco Targets Ther. 2016;9:1231–1239.
  • Moody L, Dvoretskiy S, An R, et al. The efficacy of miR-20a as a diagnostic and prognostic biomarker for colorectal cancer: a systematic review and meta-analysis. 2019;11(8):1111.
  • Sur D, Burz C, Sabarimurugan S, et al. Diagnostic and prognostic significance of MiR-150 in colorectal cancer: a systematic review and meta-analysis. J Pers Med. 2020;10. DOI:10.3390/jpm10030099
  • Garo L, Ajay A, Fujiwara M, et al. MicroRNA-146a limits tumorigenic inflammation in colorectal cancer. Nat Commun. 2021;12:2419.
  • Fang Z, Zhang L, Liao Q, et al. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer. J Exp Clin Cancer Res CR. 2017;36:17.
  • Fang Z, Deng J, Zhang L, et al. TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway. Oncol Lett. 2017;13:1797–1806.
  • He X, Wei Y, Wang Y, et al. MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1. Oncotargets Ther. 2016;9:1231–1239.
  • Liang Y, Zhao Q, Fan L, et al. Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1. Biomed Pharmacother. 2015;75:137–141.
  • Gao F, Wu H, Wang R, et al. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2. Bioengineered. 2019;10(1):1–12.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinicians. 2018;68:394–424.
  • Du H, Liu BJ. MiR-1271 as a tumor suppressor in breast cancer proliferation and progression via targeting SPIN1. Eur Rev Med Pharmacol Sci. 2018;22:2697–2706.
  • Song Q, Ji Q, Xiao J, et al. miR-409 inhibits human non-small-cell lung cancer progression by directly targeting SPIN1. Mol Ther Nucleic Acids. 2018;13:154–163.
  • Li Y, Ma X, Wang Y, et al. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Biomed Pharmacother Biomed Pharmacotherapie. 2017;93:435–443.
  • Lee Y, Dutta AJ. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227.
  • Hayes J, Peruzzi P, Lawler SJ. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20:460–469.
  • Liu Y, Liu R, Yang F, et al. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Mol Cancer. 2017;16:53.
  • Ren Y, Zhang H, Jiang PJ. MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1. Biol Res. 2018;51:51.
  • Shuai F, Wang B, Dong SJ. MicroRNA-204 inhibits the growth and motility of colorectal cancer cells by downregulation of CXCL8. Oncol Res. 2018;26:1295–1305.
  • Fang Z, Zhong M, Wang Y, et al. miR‑381 and miR‑489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/β‑catenin pathway in gastric cancer. Int J Oncol. 2019;54:733–743.
  • Gu F, Zhang J, Yan L, et al. CircHIPK3/miR-381-3p axis modulates proliferation, migration, and glycolysis of lung cancer cells by regulating the AKT/mTOR signaling pathway. Open Life Sci. 2020;15:683–695.
  • Ma H, Lv G, Zhang DH. miR-381 mediates the development of head and neck squamous cell carcinoma via targeting STC2. Oncotargets Ther. 2020;13:4485–4493.
  • Meng J, Song X, Yan G, et al. Dendrobine suppresses endoplasmic reticulum stress-induced apoptosis through upregulating microRNA miR-381-3p to decrease caspase-4. Bioengineered. 2021;12:4452–4463.
  • Sun X, Hu X, Wang X, et al. MiR-381-3p/RAB2A axis activates cell proliferation and inhibits cell apoptosis in bladder cancer. Cel Mol Biol. 2020;66:117–120.
  • Chen D, Cheng L, Cao H, et al. Role of microRNA-381 in bladder cancer growth and metastasis with the involvement of BMI1 and the Rho/ROCK axis. BMC Urol. 2021;21:5.
  • Liao W, Zhang YJ. MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway. Life Sci. 2020;254:117672.
  • Tang H, Liu X, Wang Z, et al. Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth. Brain Res. 2011;1390:21–32.
  • Papp G, Krausz T, Stricker T, et al. chromosomes, cancer. SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on both mRNA and protein levels. Genes, Chromosomes amp Cancer. 2014;53:168–176.
  • Krishnamurthy N, Kurzrock RJ. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60.
  • Drago-Ferrante R, Pentimalli F, Carlisi D, et al. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation. Oncotarget. 2017;8(17):28939–28958.